Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA58209
Max Phase: Preclinical
Molecular Formula: C17H19FO3
Molecular Weight: 290.33
Molecule Type: Small molecule
Associated Items:
ID: ALA58209
Max Phase: Preclinical
Molecular Formula: C17H19FO3
Molecular Weight: 290.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(/C=C/C=C(\C)COc1ccc(F)cc1C)=C\C(=O)O
Standard InChI: InChI=1S/C17H19FO3/c1-12(9-17(19)20)5-4-6-13(2)11-21-16-8-7-15(18)10-14(16)3/h4-10H,11H2,1-3H3,(H,19,20)/b5-4+,12-9+,13-6+
Standard InChI Key: PMJNZLWSQZJNHJ-QPCGNHOSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 290.33 | Molecular Weight (Monoisotopic): 290.1318 | AlogP: 4.05 | #Rotatable Bonds: 6 |
Polar Surface Area: 46.53 | Molecular Species: ACID | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.44 | CX Basic pKa: | CX LogP: 4.17 | CX LogD: 1.31 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.63 | Np Likeness Score: 0.39 |
1. Shealy YF, Riordan JM, Frye JL, Simpson-Herren L, Sani BP, Hill DL.. (2003) Inhibition of papilloma formation by analogues of 7,8-dihydroretinoic acid., 46 (10): [PMID:12723955] [10.1021/jm020324t] |
Source(1):